Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FXUW8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,411
Award facts
- Contract value 100% obligated
- $19,411.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 22, 2026, the Defense Logistics Agency awarded a delivery order valued at $19,411.31 to AmerisourceBergen Drug Corp for the supply of TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of January 23, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with Cencora, Inc. (doing business as AmerisourceBergen) as its parent organization.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen provides critical pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems, demonstrating its significant role in the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FXUW8?
SPE2DR26FXUW8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FXUW8 worth?
The government has obligated $19,411 on SPE2DR26FXUW8.
Is contract SPE2DR26FXUW8 an order under another contract?
Yes. SPE2DR26FXUW8 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUW8 competed?
The extent of competition for SPE2DR26FXUW8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award